Azerbaijan vs New Zealand: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Azerbaijan
88.0%
in 2025
New Zealand
88.0%
in 2025
Azerbaijan rank
76th
New Zealand rank
76th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Azerbaijan
- New Zealand
How they compare
Azerbaijan currently reports 88.0% against 88.0% in New Zealand, a difference of 0.0%.
The two have swapped places 4 times across 26 shared years of data; in 2000 it was New Zealand ahead.
Azerbaijan ranks 76th and New Zealand ranks 76th of 194 countries.
Across the 3 decades both report, Azerbaijan averaged higher in 2 and New Zealand in 1.
Head to head by decade
| Decade | Azerbaijan | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.7% | 0.0% | 63.7% | Azerbaijan |
| 2010s | 93.7% | 78.9% | 14.8% | Azerbaijan |
| 2020s | 85.0% | 85.8% | 0.8% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Azerbaijan or New Zealand?
- Azerbaijan, at 88.0% against 88.0% in New Zealand as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Azerbaijan and New Zealand?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and New Zealand?
- 26 years are reported by both, from 2000 to 2025.
- How do Azerbaijan and New Zealand rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Azerbaijan ranks 76th and New Zealand ranks 76th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.